Many experimental results have demonstrated the presence of soluble NKG2D ligands in the serum of patients with various types of cancer [39,40,41], including MM, in which soluble MICA has been correlated with a progression of the disease [42,43,44]. The gene discussed is MICA; the disease is Miyoshi myopathy.